Oncocyte Corporation

NASDAQ: OCX
Share price (3/25/25): $3.04
Market cap (3/25/25): $51.2 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

Prospectuses and Registrations Filter

Exempt offering of securities

Prospectus supplement for primary offering

Prospectus supplement

Shelf registration – amended

Shelf registration

Ownership Filter

Bio-Rad Laboratories Inc.

AWM Investment Company, Inc.

James Andrea S.

Smith Patrick W

Broadwood Partners, L.P.

News Filter

Reports Successful 2024; Sets Stage for 2025 Catalysts

Change in Directors, Officers or Compensation

Prices $29.1 Million Equity Offering Proceeds Expected to Fund Transplant Assay Through FDA IVD Clearance and Commercial Launch Strategic Partner Bio-Rad Invests, Boosts Support for Trial and Commercialization

Material Definitive Agreement, Financial Statements or Exhibits

Reports Commercial Launch Progress; on Track to Sign 20 Transplant Centers by End of 2025

Proxies Filter

Definitive proxy

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC